| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 2.06B | 6.46% |
| Operating expense | — | — |
| Net income | -381.97M | 43.19% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 6990.HK returned +15.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +36.8% |
| 1 year | +15.3% |
| All-time high | $538.00 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 6990.HK would be worth today ›No. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has not paid a dividend in the past 12 months.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is part of the Healthcare sector.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has a market cap of 125.01B HKD, based on the latest quote.
